References
1. Meng L, Wang Z, Reilly M, Zhang S, Liu X, Lin D, et al. Amniotic immune biomarkers as risk factors in women with different symptoms of threatened late miscarriage. Am J Reprod Immunol. 2020;83(5):e13232.
2. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, et al. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-67.
3. McPherson E. Recurrence of stillbirth and second trimester pregnancy loss. Am J Med Genet A. 2016;170a(5):1174-80.
4. Ekdahl L, Eoh KJ, Thumuluru KM, Butler-Manuel SA, Tae Kim Y, Lönnerfors C, et al. A combination of second trimester oral metronidazole and no sexual intercourse during second and third trimester may reduce late miscarriage and premature delivery after fertility sparing radical trachelectomy. Eur J Obstet Gynecol Reprod Biol. 2021;265:90-5.
5. Bu Z, Hu L, Su Y, Guo Y, Zhai J, Sun YP. Factors related to early spontaneous miscarriage during IVF/ICSI treatment: an analysis of 21,485 clinical pregnancies. Reprod Biomed Online. 2020;40(2):201-6.
6. Schieve LA, Tatham L, Peterson HB, Toner J, Jeng G. Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States. Obstet Gynecol. 2003;101(5 Pt 1):959-67.
7. Hu L, Du J, Lv H, Zhao J, Chen M, Wang Y, et al. Influencing factors of pregnancy loss and survival probability of clinical pregnancies conceived through assisted reproductive technology. Reprod Biol Endocrinol. 2018;16(1):74.
8. Coppens M, Folkeringa N, Teune MJ, Hamulyák K, van der Meer J, Prins MH, et al. Outcome of the subsequent pregnancy after a first loss in women with the factor V Leiden or prothrombin 20210A mutations. J Thromb Haemost. 2007;5(7):1444-8.
9. Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.
10. Kling C, Magez J, Hedderich J, von Otte S, Kabelitz D. Two-year outcome after recurrent first trimester miscarriages: prognostic value of the past obstetric history. Arch Gynecol Obstet. 2016;293(5):1113-23.
11. Zeng H, Liu N, Fan X, Cai M, Xie H. [Risk factors for early miscarriage among intrauterine singleton pregnancies after treatment with in vitro fertilization/intracytoplasmic sperm injection]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2016;41(8):815-20.
12. Edlow AG, Srinivas SK, Elovitz MA. Second-trimester loss and subsequent pregnancy outcomes: What is the real risk? Am J Obstet Gynecol. 2007;197(6):581.e1-6.
13. Egerup P, Kolte AM, Larsen EC, Krog M, Nielsen HS, Christiansen OB. Recurrent pregnancy loss: what is the impact of consecutive versus non-consecutive losses? Hum Reprod. 2016;31(11):2428-34.
14. Ni T, Wu Q, Zhu Y, Jiang W, Zhang Q, Li Y, et al. Comprehensive analysis of the associations between previous pregnancy failures and blastocyst aneuploidy as well as pregnancy outcomes after PGT-A. J Assist Reprod Genet. 2020;37(3):579-88.
15. Kling C, Hedderich J, Kabelitz D. Fertility after recurrent miscarriages: results of an observational cohort study. Arch Gynecol Obstet. 2018;297(1):205-19.
16. Bender Atik R, Christiansen OB, Elson J, Kolte AM, Lewis S, Middeldorp S, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):hoy004.
17. Guo Z, Xu X, Zhang L, Zhang L, Yan L, Ma J. Endometrial thickness is associated with incidence of small-for-gestational-age infants in fresh in vitro fertilization-intracytoplasmic sperm injection and embryo transfer cycles. Fertil Steril. 2020;113(4):745-52.
18. Puissant F, Van Rysselberge M, Barlow P, Deweze J, Leroy F. Embryo scoring as a prognostic tool in IVF treatment. Hum Reprod. 1987;2(8):705-8.
19. Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999;11(3):307-11.
20. Cai H, Mol BW, Gordts S, Wang H, Wang T, Li N, et al. Early and late pregnancy loss in women with polycystic ovary syndrome undergoing IVF/ICSI treatment: a retrospective cohort analysis of 21 820 pregnancies. Bjog. 2021;128(7):1160-9.
21. Joubert M, Sibiude J, Bounan S, Mandelbrot L. Mid-trimester miscarriage and subsequent pregnancy outcomes: the role of cervical insufficiency in a cohort of 175 cases. J Matern Fetal Neonatal Med. 2021:1-6.
22. Diamant H, Mastrolia SA, Weintraub AY, Sheizaf B, Zilberstein T, Yohay D. Effectiveness and safety of late midtrimester cervical cerclage. J Matern Fetal Neonatal Med. 2019;32(18):3007-11.
23. Wang SW, Ma LL, Huang S, Liang L, Zhang JR. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History. Chin Med J (Engl). 2016;129(22):2670-5.
24. Chen R, Huang X, Li B. Pregnancy outcomes and factors affecting the clinical effects of cervical cerclage when used for different indications: A retrospective study of 326 cases. Taiwan J Obstet Gynecol. 2020;59(1):28-33.
25. Hirayama E, Ebina Y, Kato K, Akabane-Nakagawa K, Okuyama K. Cervical polyps in early pregnancy are a risk factor for late abortion and spontaneous preterm birth: A retrospective cohort study. Int J Gynaecol Obstet. 2022;156(1):64-70.
26. Kutteh WH, Triplett DA. Thrombophilias and recurrent pregnancy loss. Semin Reprod Med. 2006;24(1):54-66.
27. Rey E, Kahn SR, David M, Shrier I. Thrombophilic disorders and fetal loss: a meta-analysis. Lancet. 2003;361(9361):901-8.
28. Robertson L, Wu O, Langhorne P, Twaddle S, Clark P, Lowe GD, et al. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006;132(2):171-96.
29. Simcox LE, Ormesher L, Tower C, Greer IA. Thrombophilia and Pregnancy Complications. Int J Mol Sci. 2015;16(12):28418-28.
30. Cicinelli E, Matteo M, Tinelli R, Pinto V, Marinaccio M, Indraccolo U, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014;21(5):640-7.
31. Sakamoto J, Michels C, Eisfelder B, Joshi N. Trauma in Pregnancy. Emerg Med Clin North Am. 2019;37(2):317-38.
32. El-Kady D, Gilbert WM, Anderson J, Danielsen B, Towner D, Smith LH. Trauma during pregnancy: an analysis of maternal and fetal outcomes in a large population. Am J Obstet Gynecol. 2004;190(6):1661-8.
33. Liu S, Mo M, Xiao S, Li L, Hu X, Hong L, et al. Pregnancy Outcomes of Women With Polycystic Ovary Syndrome for the First In Vitro Fertilization Treatment: A Retrospective Cohort Study With 7678 Patients. Front Endocrinol (Lausanne). 2020;11:575337.
34. Song Y, Ye W, Ye H, Xie T, Shen W, Zhou L. Serum testosterone acts as a prognostic indicator in polycystic ovary syndrome-associated kidney injury. Physiol Rep. 2019;7(16):e14219.